Table 7.
Survival rates in prior clinical trials with polysialic acid vaccines
Trial 02-097 (n = 18) | Trial 98-065 (n = 6) | Trial 02-097 and trial 98-65 combined (n = 24) | |
---|---|---|---|
1-year survival rate (±standard deviation) | 66.7 (±11.1) | 50.0 (±20.4) | 62.5 (±9.9) |
2-year survival rate (±standard deviation) | 44.4 (±11.7) | 33.3 (±19.2) | 45.8 (±10.2) |
Median survival, months (95% confidence interval) | 22.9 (11.3–NR) | 17.6 (7.97–NR) | 22.9 (11.3–37.2) |
NR not reached